In Japan, where heart disease is the second leading cause of death (220,444 deaths in 2025), it was introduced on X that ...

Coverage of a new PCSK9 trial makes bold claims about prevention and risk reduction. But how well do they hold up to scrutiny ...

Amgen enters October with fresh Phase 3 pipeline wins, strong growth from Repatha and Imdelltra, and MariTide advancing ...

The change will require tens of thousands of patients who use the VA health care system to have documented discussions with ...

Amgen said its experimental drug dazodalibep met the main goal in a late-stage Sjogren’s disease trial at 48 weeks.

Pharmacogenomics looks at the relationship between an individual's genetic information and their response to prescription drugs. This information can be useful in making recommendations with regard to ...

Vesalius-CV initially read out last fall, supporting Repatha’s ability to significantly curb the risk of major adverse cardiovascular events over standard-of-care treatment alone in people who hadn’t ...

Amgen (AMGN) said Monday its cholesterol buster, Repatha, reduced the risk of death by 20% in a study of more than 12,000 high-risk patients. The results could help boost sales of one of the company's ...

Amgen (AMGN) said new findings from a pre-specified Phase 3 VESALIUS-CV trial analysis showed Repatha (evolocumab) reduced the risk of death by 20% in high-risk adults without a prior heart attack or ...

The U.S. Drug Enforcement Administration submitted a final telemedicine special registration rule for review on Tuesday to the Office of Management and Budget's Office of Information and Regulatory ...

Credit: Getty Images This fact sheet explains what other drugs are used as statin alternatives. A heart-healthy diet limits food that is high in saturated fats, such as some meats, dairy products, ...

President Donald J. Trump promised to slash prescription drug prices — and he has delivered. New data confirms prescription drug prices just recorded their largest annual decline in more than 60 years ...